HENDERSON, Nev., Aug. 22, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, today announced that management will participate in a pair of upcoming investor conferences. Three Part Advisors Midwest IDEAS Conference Research Solutions, Inc. Logo (PRNewsfoto/Research Solutions, Inc.)Research Solutions, Inc. Logo (PRNewsfoto/Research Solutions, Inc.) August 28, 2024; Chicago, IL Group presentation at 3:00pm ET and 1- ...

Expects Record Revenue and Income from Operations, Continued Strong Cash Flow HENDERSON, Nev., Aug. 19, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, announced selected preliminary financial results for its fiscal fourth quarter and fiscal year ended June 30, 2024. Based on preliminary unaudited information, Research Solutions expects the following results for its fiscal fourth qua ...

This collaboration will make Scite's award-winning AI platform more affordable and accessible for more than 280 higher education and research institutions in the UK. It aims to advance research quality by leveraging ethical AI technology. Scite is utilized by researchers and institutions worldwide, underscoring its global impact and commitment to advancing scientific research and innovation. HENDERSON, Nev., July 30, 2024 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-b ...

Company Overview - Research Solutions operates five wholly owned subsidiaries as of March 31, 2024, including Reprints Desk, Scite, and Resolute Innovation[109]. - The company provides over 100 million existing STM articles and publishes 2 to 4 million new STM articles each year, facilitating single article delivery in under one hour, often in under one minute[119]. - The company has arrangements with hundreds of content publishers, allowing for rapid electronic delivery of articles while ensuring compliance with copyright laws[120]. Revenue Sources - Revenue is derived from two main sources: annual licenses for cloud-based SaaS platforms and transactional sales of STM content, with revenue recognized upon delivery of services[126]. - The company charges a subscription fee for access to premium features of its platforms, with revenue recognized ratably over the subscription term, typically one year[127]. Financial Performance - Total revenue for Q1 2024 reached $12,115,672, representing a 17.1% increase from $10,342,426 in Q1 2023[134]. - Platforms revenue increased by 75.7% to $3,953,403 compared to $2,249,632 in the same quarter last year[134]. - Gross profit for Q1 2024 was $5,481,932, a 36.1% increase from $4,027,273 in Q1 2023[134]. - Total operating expenses rose to $5,394,269, up 38.5% from $3,894,134 in Q1 2023[134]. - Net income for Q1 2024 was $76,301, a decrease of 67.8% from $236,842 in Q1 2023[134]. - For the nine months ended March 31, 2024, total revenue was $32,490,385, up 17.1% from $27,743,735 in the same period last year[135]. - Platforms revenue for the nine months increased by 51.7% to $9,679,179 compared to $6,379,871 in the previous year[135]. - Total gross profit for the nine months was $13,997,300, reflecting a 29.8% increase from $10,780,348 in the same period last year[135]. - The company reported a net loss of $(965,370) for the nine months ended March 31, 2024, compared to a net income of $195,877 in the same period last year[135]. Operating Expenses - Operating expenses increased by $1,500,135, or 38.5%, for the three months ended March 31, 2024, primarily due to higher sales and marketing costs and technology development expenses[145]. - The company reported a significant increase in personnel costs due to the onboarding from ResoluteAI and Scite transactions, impacting both sales and marketing and technology development expenses[145]. Cash Flow and Investments - Cash and cash equivalents decreased to $4,221,424 as of March 31, 2024, down from $13,545,333 as of June 30, 2023, primarily due to cash used in investing activities[150]. - Net cash used in investing activities for the nine months ended March 31, 2024, was $10,081,507, mainly from the Scite acquisition of $7,305,493 and the ResoluteAI acquisition of $2,718,253[154]. - Net cash used in financing activities for the nine months ended March 31, 2024, was $836,984, resulting from the repurchase of common stock of $522,024 and payment of contingent acquisition consideration of $314,960[155]. Adjusted EBITDA and Stock-Based Compensation - Adjusted EBITDA for the nine months ended March 31, 2024, was $838,311, a decrease of $355,812 compared to $1,194,123 for the same period in 2023[160]. - The company reported an increase in stock-based compensation to $1,729,271 for the nine months ended March 31, 2024, compared to $1,264,522 in the prior year[160]. Future Outlook and Risks - Future plans include releasing several new platform solutions to support analysis functions for research organizations[117]. - Inflation has not materially affected operations to date, but there is a risk of increased operating costs due to inflationary pressures in the future[121]. Financial Agreements - The company entered into a new PNC Loan Agreement providing a $500,000 secured revolving line of credit maturing on April 15, 2025[157]. - The company had no outstanding borrowings on its previous line of credit with Silicon Valley Bank at maturity on February 28, 2024[156]. - The company does not have any off-balance sheet arrangements[161].

Research Solutions, Inc. (NASDAQ:RSSS) Q3 2024 Results Conference Call May 9, 2024 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - President & Chief Executive Officer Bill Nurthen - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Allen Klee - Maxim Group Operator Good day, ladies and gentlemen, and welcome to this Research Solutions, Inc. Conference Call. At this time, all participants are in a listen-only mode, and later, ...

Revenue Growth - Total revenue increased by 17% to $12.1 million, driven by platform revenue growth[4][5] - Platform revenue grew 76% to $4.0 million, with Annual Recurring Revenue (ARR) up 82% to $16.6 million[5][6] - Total revenue for Q1 2024 was $12,115,672, a 17.1% increase from $10,342,426 in Q1 2023[21] Profitability Metrics - Gross profit increased by 36%, with total gross margin improving 630 basis points to 45.2%[5][8] - Adjusted EBITDA reached a company record of $961,000, a 71.8% increase from the prior-year quarter[5][9] - Adjusted EBITDA for Q1 2024 was $960,740, a 71.8% increase from $559,382 in Q1 2023[15] - Gross profit for Q1 2024 was $5,481,932, a 36.1% increase from $4,027,273 in Q1 2023[21] Customer and Transaction Metrics - Transaction revenue was $8.2 million, with 1,426 active customers, a slight increase from 1,417 in the prior-year quarter[7] - Active customer accounts are defined as the sum of total customers per month divided by the number of months in the period, with customers having at least one transaction per month[12] - B2B ARR increased by 27.9% to $11.65 million, while B2C ARR reached $4.9 million[11] - Annual Recurring Revenue (ARR) is calculated as the annualized value of monthly subscriptions, multiplied by twelve for B2C ARR[13] Operating Expenses and Net Income - Total operating expenses increased by 38.5% to $5.4 million, primarily due to acquisitions[8] - Net income was $76,000, compared to $237,000 in the prior-year quarter[9] - Net income for Q1 2024 was $76,301, a 67.8% decrease from $236,842 in Q1 2023[15] - Net income (loss) for the nine months ended March 31, 2024, was $(965,370), compared to $195,877 in the same period in 2023[23] Cash Flow and Financial Position - Quarterly cash flow from operations exceeded $2 million, a company quarterly record[5] - Cash and cash equivalents as of March 31, 2024, were $4,221,424, a decrease from $13,545,333 as of June 30, 2023[19] - Accounts receivable as of March 31, 2024, were $7,323,379, an increase from $6,153,063 as of June 30, 2023[19] - Total assets as of March 31, 2024, were $40,803,199, an increase from $21,834,727 as of June 30, 2023[19] - Total liabilities as of March 31, 2024, were $26,674,940, an increase from $14,504,240 as of June 30, 2023[19] - Net cash provided by operating activities for the nine months ended March 31, 2024, was $1,589,791, down from $1,872,356 in the same period in 2023[23] - Net cash used in investing activities for the nine months ended March 31, 2024, was $(10,081,507), primarily due to acquisitions of Resolute and Scite[23] - Net cash used in financing activities for the nine months ended March 31, 2024, was $(836,984), including common stock repurchases of $(522,024)[23] - Cash and cash equivalents decreased by $9,323,909 to $4,221,424 at the end of March 31, 2024, from $13,545,333 at the beginning of the period[23] Depreciation, Amortization, and Other Expenses - Depreciation and amortization expenses increased to $525,267 for the nine months ended March 31, 2024, from $30,486 in the same period in 2023[23] - Fair value of vested restricted common stock increased to $1,603,820 for the nine months ended March 31, 2024, from $925,550 in the same period in 2023[23] - Accounts receivable decreased by $739,883 for the nine months ended March 31, 2024, compared to a decrease of $1,545,695 in the same period in 2023[23] - Deferred revenue increased by $768,347 for the nine months ended March 31, 2024, compared to an increase of $986,044 in the same period in 2023[23] - Cash paid for income taxes increased to $82,049 for the nine months ended March 31, 2024, from $5,543 in the same period in 2023[23] Product Launches - The company launched two new product offerings: Technology Landscape and Clinical Trial Landscape[3]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charter ...

Research Solutions, Inc. (NASDAQ:RSSS) Q2 2024 Earnings Conference Call February 8, 2024 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - President & Chief Executive Officer William Nurthen - Chief Financial Officer Conference Call Participants Allen Klee - Maxim Group Operator Good day and welcome to the Research Solutions, Inc. Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now lik ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charte ...

Research Solutions, Inc. (NASDAQ:RSSS) Q1 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - Chief Executive Officer and President William Nurthen - Chief Financial Officer Conference Call Participants Richard Baldry - ROTH Capital Allen Klee - Maxim Group Operator Thank you for standing by. This is the conference operator. Welcome to the Research Solutions Inc. First Quarter 2024 Earnings Conference Call. As a ...